Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Intervention1: Erector spinae block (Group E): Group E : 0.25% levobupivacaine 30ml
Control Intervention1: Paravertebral block (Group P): O.25% levobupivacaine 30ml
Sponsors
Dr A.Devraajulu
Eligibility
Inclusion criteria
Inclusion criteria: ASA Class 1 or 2 BMI 18 to 35 kg/m2
Exclusion criteria
Exclusion criteria: Patient refusal Know Hypersensitivity to LA Chronic systemic illness Bleeding diathesis Infection at local site Pregnancy Patient with spinal deformities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the time to first rescue analgesia in both study groups.Timepoint: 30mins,60mins,120mins4hrs,8hrs,12hrs,24hrs,48hrs. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the total tramadol consumption for 1st 24hrs. VAS score at 1hr,4hrs,12hrs,24hrs. Complications following erector spinae block and paravertebral blockTimepoint: 30mins,60mins,120mins,4hrs,8hrs,12hrs,24hrs,48hrs. | — |
Countries
India
Contacts
Public ContactRKrishnaprabu
Sri Venkateswara medical college hospital and research centre
Outcome results
None listed